UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 15 von 83
Datensatz exportieren als...
BibTeX
Multiple‐species candidemia in patients with cancer
Cancer, 2004-10, Vol.101 (8), p.1860-1865
Boktour, Maha R.
Kontoyiannis, Dimitrios P.
Hanna, Hend A.
Hachem, Ray Y.
Girgawy, Essam
Bodey, Gerald P.
Raad, Issam I.
2004
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Boktour, Maha R.
Kontoyiannis, Dimitrios P.
Hanna, Hend A.
Hachem, Ray Y.
Girgawy, Essam
Bodey, Gerald P.
Raad, Issam I.
Titel
Multiple‐species candidemia in patients with cancer
Ist Teil von
Cancer, 2004-10, Vol.101 (8), p.1860-1865
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2004
Quelle
MEDLINE
Beschreibungen/Notizen
BACKGROUND Candidemia is a common cause of bloodstream infections in patients with cancer, with the majority of these infections being caused by a single Candida species. Studies of multiple‐species candidemia (MSC) have rarely been reported. METHODS The authors identified 33 patients with cancer who had candidemia (diagnosed between 1993 and 2000) caused by more than 1 Candida species. This group of 33 patients was compared with a control group of 66 patients with cancer who had C. albicans candidemia that arose soon before or soon after each case of MSC that was investigated in the current study. RESULTS Patients with MSC, compared with control patients, were more likely to have leukemia (33% vs. 8%; P = 0.001), to have had prolonged neutropenia before the onset of their infection (mean ± standard deviation, 10 ± 17 days vs. 3 ± 6 days; P = 0.02), and to have received chemotherapy within 1 month before their infection (42% vs. 18%; P = 0.01). Patients with MSC also had higher Acute Physiology and Chronic Health Evaluation II scores at the onset of infection (score ≥ 16, 45% vs. 26%; P = 0.05) and were more likely to have received previous antifungal prophylaxis compared with patients who had candidemia caused by C. albicans (33% vs. 11%; P = 0.006). The response of C. albicans candidemia to single‐agent antifungal therapy was significantly better than that of MSC (69% vs. 35% P = 0.004). CONCLUSIONS In patients with cancer, MSC was more likely to occur as breakthrough candidemia, predominantly in those with leukemia and prolonged neutropenia, and was associated with suboptimal responses to single‐agent antifungal therapy. Cancer 2004. © 2004 American Cancer Society. Candidemia is a common cause of bloodstream infections in patients with cancer, with the majority of these infections being caused by a single Candida species. In the current study of patients with cancer who were affected by multiple‐species candidemia (MSC), the authors found that MSC was more likely to occur as breakthrough candidemia, particularly in those with leukemia and prolonged neutropenia, and was associated with suboptimal responses to single‐agent antifungal therapy.
Sprache
Englisch
Identifikatoren
ISSN: 0008-543X
eISSN: 1097-0142
DOI: 10.1002/cncr.20573
Titel-ID: cdi_proquest_miscellaneous_66954933
Format
–
Schlagworte
Antifungal Agents - therapeutic use
,
APACHE
,
Biological and medical sciences
,
cancer
,
Candida - classification
,
Candida - isolation & purification
,
candidemia
,
Candidiasis - epidemiology
,
Candidiasis - microbiology
,
Candidiasis - prevention & control
,
Female
,
fungal infections
,
Fungemia - epidemiology
,
Fungemia - microbiology
,
Fungemia - prevention & control
,
Humans
,
Incidence
,
Male
,
Medical sciences
,
Middle Aged
,
multiple species
,
Neoplasms - drug therapy
,
Neoplasms - microbiology
,
Neutropenia - drug therapy
,
Neutropenia - microbiology
,
Retrospective Studies
,
Treatment Outcome
,
Tumors
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX